AER THERAPEUTICS

aer-therapeutics-logo

Aer Therapeutics is a clinical-stage biopharmaceutical company that develops an approach to treat lung disease with excess mucus and mucus plugs. The company focuses on treating respiratory diseases with significant unmet needs, such as COPD, cystic fibrosis, and asthma.

#SimilarOrganizations #People #Financial #Website #More

AER THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Medical Therapeutics

Founded:
2014-01-01

Address:
Raleigh, North Carolina, United States

Country:
United States

Website Url:
http://www.aertherapeutics.com

Total Employee:
1+

Status:
Active

Total Funding:
36 M USD

Technology used in webpage:
Google Maps U.S. Server Location


Similar Organizations

carisma-therapeutics-logo

Carisma Therapeutics

Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

crinetics-pharmaceuticals-logo

Crinetics Pharmaceuticals

Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics.

eikon-therapeutics-logo

Eikon Therapeutics

Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.

eureka-therapeutics-logo

Eureka Therapeutics

Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.

immune-onc-therapeutics-logo

Immune-Onc Therapeutics

Immune-Onc Therapeutics is a newly established biopharmaceutical company that develops therapeutic antibodies for cancer treatment.

latigo-biotherapeutics-logo

Latigo Biotherapeutics

Operator of a drug discovery company intended to develop novel, non-opioid therapies for chronic pain.

onkure-therapeutics-logo

OnKure Therapeutics

OnKure is a biotechnology company that commercializes a new cancer therapy based on novel, less toxic kinase inhibitor drugs.

silk-road-medical-logo

Silk Road Medical

Silk Road Medical provides research and development services of medical devices for neurovascular diseases.


Current Advisors List

rishi-gupta_image

Rishi Gupta Board of Directors @ Aer Therapeutics
Board_member
2023-04-13

mark-eisner_image

Mark Eisner Scientific Advisory Board Member @ Aer Therapeutics
Board_member
2021-09-01

thomas-mathers_image

Thomas Mathers Board of Directors @ Aer Therapeutics
Board_member
2023-04-13

timothy-shannon_image

Timothy Shannon Board of Directors @ Aer Therapeutics
Board_member
2023-04-13

christy-l-shaffer_image

Christy L. Shaffer Board of Directors @ Aer Therapeutics
Board_member
2023-04-13

Current Employees Featured

john-fahy_image

John Fahy
John Fahy Founder @ Aer Therapeutics
Founder
2020-08-01

Founder


john-fahy_image

John Fahy

Investors List

hatteras-venture-partners_image

Hatteras Venture Partners

Hatteras Venture Partners investment in Series A - Aer Therapeutics

canaan-partners_image

Canaan Partners

Canaan Partners investment in Series A - Aer Therapeutics

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series A - Aer Therapeutics

Official Site Inspections

http://www.aertherapeutics.com Semrush global rank: 5.69 M Semrush visits lastest month: 1.24 K

  • Host name: 141.193.213.11
  • IP address: 141.193.213.11
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Aer Therapeutics"

About - Aer Therapeutics

Our mission is to advance the treatment paradigm for mucus mediated lung diseases. Aer Therapeutics is a clinical-stage biopharmaceutical company dedicated to delivering a โ€ฆSee details»

Aer Therapeutics - Crunchbase Company Profile & Funding

Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.See details»

Aer Therapeutics, Inc. | LinkedIn

Aer Therapeutics is a clinical stage biopharmaceutical company developing a novel inhaled approach to treat lung disease with excess mucus and mucus plugs.See details»

AER THERAPEUTICS, INC. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for AER THERAPEUTICS, INC. of Raleigh, NC. Get the latest business insights from Dun & Bradstreet.See details»

Aer Therapeutics, Inc. - Company Profile & Staff Directory

Aer Therapeutics is a clinical stage biopharmaceutical company developing a novel inhaled approach to treat lung disease with excess mucus and mucus plugs. We are focused on โ€ฆSee details»

Aer Therapeutics - PitchBook

Aer Therapeutics General Information Description. Operator of a biopharmaceutical company intended to treat lung disease with excess mucus and mucus plugs. The company focuses on โ€ฆSee details»

Aer Therapeutics Company Profile - Office Locations ... - Craft

Aer Therapeutics has 5 employees at their 1 location and $36 m in total funding,. See insights on Aer Therapeutics including office locations, competitors, revenue, financials, executives, โ€ฆSee details»

Aer Therapeutics | North Carolina Biotech Center

Aer Therapeutics is a clinical stage biopharmaceutical company developing a novel inhaled approach to treat lung diseases with excess mucus and mucus plugs.See details»

Our Science - Aer Therapeutics

Mucus Dysregulation in COPD and Asthma Causes Mucus Plug Formation and Airway Obstruction. The airways of the lungs are protected from environmental injury by a mucus gel comprised of mucin glycoproteins (โ€œmucinsโ€). 1-7 In โ€ฆSee details»

Aer Therapeutics - Competitors, Industries, Business Signals

Aertherapeutics.com. Industries. Biotechnology Biotechnology and Life Sciences. Social Media Profiles. LinkedIn. About Aer Therapeutics. Description. Aer Therapeutics is a clinical-stage โ€ฆSee details»

Aer Therapeutics - Overview, News & Similar companies - ZoomInfo

View Aer Therapeutics (aertherapeutics.com) location in North Carolina, United States , revenue, industry and description. Find related and similar companies as well as employees by title and โ€ฆSee details»

Irish-founded Aer Therapeutics raises $36m for COPD treatment

Apr 14, 2023 Founded by researchers based in UCD and San Francisco, Aer Therapeutics is developing a novel drug to help COPD patients breathe easier. Aer Therapeutics, an Irish โ€ฆSee details»

Aer Therapeutics, Inc. โ€“ Funding, Valuation, Investors, News

Aug 30, 2023 Aer Therapeutics is a clinical stage biopharmaceutical company developing a novel inhaled approach to treat lung disease with excess mucus and mucus plugs. We are โ€ฆSee details»

Aer Therapeutics, Inc. | BioPharm America - informaconnect.com

Aer Therapeutics is a clinical-stage biopharmaceutical company dedicated to delivering a therapeutic solution to patients suffering from muco-obstructive lung diseases.See details»

Aer Therapeutics Closes $36 Million Series A to Advance โ€ฆ

Apr 13, 2023 Learn more at: www.aertherapeutics.com. Contacts: Aer Therapeutics Jim Shaffer [email protected] 919-345-4256. Vida Strategic Partners (on behalf of Aer Therapeutics) Tim โ€ฆSee details»

Aer Therapeutics | CipherBio

Explore Aer Therapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»

Aer Therapeutics - VentureRadar

Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and โ€ฆSee details»

News & Publications - Aer Therapeutics

Apr 13, 2023 Phase 1 clinical trials of its lead drug candidate AER-01 will start in 2023 with potential to expand development into multiple other indications such as asthma, bronchiectasis โ€ฆSee details»

Aer Therapeutics Announces First Patient Dosed in Phase 2

3 days ago Learn more at: www.aertherapeutics.com. Forward-Looking Statements Certain of the statements made in this press release are forward looking, such as those, among others, โ€ฆSee details»

Press Releases - Aer Therapeutics

April 13, 2023. Aer Therapeutics Closes $36 Million Series A to Advance Development of AER-01, an Innovative Mucolytic for the Treatment of Lung DiseasesSee details»

linkstock.net © 2022. All rights reserved